Hunan Fangsheng Pharmaceutical Co Ltd
SSE:603998
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Walmart Inc
NYSE:WMT
|
Retail
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
7.46
13.11
|
Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
UnitedHealth Group Inc
NYSE:UNH
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Walmart Inc
NYSE:WMT
|
US | |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Hunan Fangsheng Pharmaceutical Co Ltd
Total Liabilities
Hunan Fangsheng Pharmaceutical Co Ltd
Total Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Total Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
Hunan Fangsheng Pharmaceutical Co Ltd
SSE:603998
|
Total Liabilities
ÂĄ1.7B
|
CAGR 3-Years
7%
|
CAGR 5-Years
17%
|
CAGR 10-Years
32%
|
||
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Total Liabilities
ÂĄ7.2B
|
CAGR 3-Years
35%
|
CAGR 5-Years
4%
|
CAGR 10-Years
N/A
|
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
Total Liabilities
ÂĄ3.4B
|
CAGR 3-Years
9%
|
CAGR 5-Years
9%
|
CAGR 10-Years
17%
|
||
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Total Liabilities
ÂĄ5.6B
|
CAGR 3-Years
6%
|
CAGR 5-Years
15%
|
CAGR 10-Years
17%
|
||
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Total Liabilities
ÂĄ15B
|
CAGR 3-Years
2%
|
CAGR 5-Years
5%
|
CAGR 10-Years
14%
|
||
S
|
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
|
Total Liabilities
ÂĄ1.3B
|
CAGR 3-Years
29%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Hunan Fangsheng Pharmaceutical Co Ltd
Glance View
Hunan Fangsheng Pharmaceutical Co., Ltd. engages in the manufacture, distribution, research and development of pharmaceutical products. The company is headquartered in Changsha, Hunan and currently employs 2,808 full-time employees. The company went IPO on 2014-12-05. The firm's main products include Xuesaitong Dispersible Tablets, Xuesaitong Tablets, Tenghuang Jiangu Tablets, Dieda Huoxue Capsules, Lysine Dimension B12 Granules, Cefixoxime Tablets and Jinying Capsules. The firm distributes its products primarily in domestic market.
See Also
What is Hunan Fangsheng Pharmaceutical Co Ltd's Total Liabilities?
Total Liabilities
1.7B
CNY
Based on the financial report for Sep 30, 2024, Hunan Fangsheng Pharmaceutical Co Ltd's Total Liabilities amounts to 1.7B CNY.
What is Hunan Fangsheng Pharmaceutical Co Ltd's Total Liabilities growth rate?
Total Liabilities CAGR 10Y
32%
Over the last year, the Total Liabilities growth was 2%. The average annual Total Liabilities growth rates for Hunan Fangsheng Pharmaceutical Co Ltd have been 7% over the past three years , 17% over the past five years , and 32% over the past ten years .